# ProQR Therapeutics (PRQR) — Overview

PRQR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/prqr

## Price

Last close $1.45 on Oct 15, 2026. 52-week range $1.37 – $3.05.

## Company profile

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $21.2M |
| Revenue (quarter) | $10.0M |
| Revenue growth (year over year) | 122.59% |
| Gross profit (trailing twelve months) | $21.2M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$48.6M |
| Net income (quarter) | −$10.0M |
| Net income growth (year over year) | 30.48% |
| Net margin | -229.27% |
| Return on equity | -57.26% |
| EPS (trailing twelve months) | −$0.46 |
| Book value per share | $0.64 |
| P/E (trailing twelve months) | — |
| Price to book | 2.3 |
| Debt to assets | 40.49% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is ProQR Therapeutics (PRQR) profitable?

No. ProQR Therapeutics reported a net loss of $48.6M over the trailing twelve months.

### How much revenue does ProQR Therapeutics (PRQR) make?

ProQR Therapeutics generated $21.2M in revenue over the trailing twelve months, up 122.59% year over year.

### How do I buy stock in ProQR Therapeutics (PRQR)?

PRQR trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).